These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 4585571

  • 1. [Comparison between propranolol and methyldopa in the treatment of hypertension (a double-blind trial)].
    Brahm M.
    Ugeskr Laeger; 1973 May 17; 135(20):974-6. PubMed ID: 4585571
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial.
    Whelton PK, Russell RP, Sova-Schulz K, Wyndham R, Walker WG.
    J Cardiovasc Pharmacol; 1979 May 17; 1(6 Suppl):S28-37. PubMed ID: 94637
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L, Waeber B, Brunner HR.
    Schweiz Med Wochenschr; 1983 Mar 05; 113(9):331-8. PubMed ID: 6342133
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The position of beta-blockers in antihypertensive therapy. Comparison with other antihypertensive agents.
    Brunner HR, Waeber B, Ferguson RK, Turini GA, Gavras H.
    Cardiology; 1979 Mar 05; 64 Suppl 1():88-95. PubMed ID: 42489
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antihypertensive activity of alpha-methyldopa on a twice daily regimen in comparison to metoprolol. A multi-centre controlled clinical trial.
    Muiesan G, Agabiti-Rosei E, Alicandri C, Motolese M.
    Clin Exp Pharmacol Physiol Suppl; 1978 Mar 05; 4():35-41. PubMed ID: 354827
    [Abstract] [Full Text] [Related]

  • 10. Comparison of prazosin and methyldopa in mild to moderate hypertension, a multicenter cooperative study.
    Bradley WF, Hoffman FG, Hutchison JC, Kalams Z, Waldron SL.
    Curr Ther Res Clin Exp; 1977 Jan 05; 21(1):28-35. PubMed ID: 401709
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An assessment of adverse effects of methyldopa and propranolol.
    Schnaper HW, Collins MA.
    J Med Assoc State Ala; 1979 Oct 05; 49(4):35, 37, 41-2 passim. PubMed ID: 501257
    [No Abstract] [Full Text] [Related]

  • 15. Double blind study with propranolol in the treatment of hypertension.
    De Tollenaere G.
    Brux Med; 1973 Nov 05; Spec No(0):99-110. PubMed ID: 4609568
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antihypertensive effect of sotalol and propranolol a double-blind crossover study.
    Berglund G.
    Curr Ther Res Clin Exp; 1977 Jan 05; 21(1):21-7. PubMed ID: 401708
    [No Abstract] [Full Text] [Related]

  • 20. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.
    Mroczek WJ, Fotiu S, Davidov ME, Finnerty FA.
    Curr Ther Res Clin Exp; 1974 Aug 05; 16(8):769-77. PubMed ID: 4217243
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.